SERUM IGE CONCENTRATIONS, DISEASE-ACTIVITY, AND ATOPIC DISORDERS IN SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:0
|
作者
ELKAYAM, O
TAMIR, R
PICK, AI
WYSENBEEK, A
机构
[1] BEILINSON MED CTR,DIV ALLERGY & CLIN IMMUNOL,IL-49100 TEL AVIV,ISRAEL
[2] BEILINSON MED CTR,RHEUMATOL UNIT,IL-49100 TEL AVIV,ISRAEL
[3] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
关键词
ATOPY; HYPERSENSITIVITY; IGE; NEPHRITIS; SLE PATHOGENESIS;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
We investigated the relationship between disease activity and total IgE concentration in the sera of patients with active systemic lupus erythematosus (SLE). In addition, the prevalence of personal and family history of allergic rhinitis and asthma were examined with a questionnaire and immediate skin tests for common inhalant allergens in 24 patients in remission. In the 20 patients with active disease, we found that IgE concentration was significantly higher during the periods of active disease than the periods of remission. This elevation was not associated with an elevation in total serum IgG concentrations. The increase in IgE concentration during disease activity in patients with active nephritis was significantly higher than in patients without nephritis. Of the 24 patients in remission, only one reported allergic rhinitis, and two had positive skin tests for inhalant allergens. We concluded that, although patients with SLE do not have an increased rate of atopic disorders, serum IgE rises during disease activity and is associated with active nephritis. This phenomenon suggests that IgE may be involved in the pathogenesis of SLE, particularly in patients with nephritis.
引用
收藏
页码:94 / 96
页数:3
相关论文
共 50 条
  • [1] SERUM THROMBOMODULIN - A NOVEL MARKER OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BOEHME, MWJ
    NAWROTH, PP
    KLING, E
    LIN, J
    AMIRAL, J
    RIEDESEL, J
    RAETH, U
    SCHERBAUM, WA
    ARTHRITIS AND RHEUMATISM, 1994, 37 (04): : 572 - 577
  • [2] HYPERPROLACTINEMIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS - ASSOCIATION WITH DISEASE-ACTIVITY
    JARA, LJ
    GOMEZSANCHEZ, C
    SILVEIRA, LH
    MARTINEZOSUNA, P
    VASEY, FB
    ESPINOZA, LR
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (04): : 222 - 226
  • [3] FIBROMYALGIA SYNDROME AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    MORAND, EF
    MILLER, MH
    WHITTINGHAM, S
    LITTLEJOHN, GO
    LUPUS, 1994, 3 (03) : 187 - 191
  • [4] RETINOPATHY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATIONSHIP TO DISEASE-ACTIVITY
    KLINKHOFF, AV
    BEATTIE, CW
    CHALMERS, A
    ARTHRITIS AND RHEUMATISM, 1986, 29 (09): : 1152 - 1156
  • [5] SEROLOGICAL MARKERS OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SPRONK, PE
    LIMBURG, PC
    KALLENBERG, CGM
    LUPUS, 1995, 4 (02) : 86 - 94
  • [6] CRITERIA FOR ASSESSING DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ISENBERG, D
    BACON, P
    BOMBARDIER, C
    GLADMAN, D
    GOLDSMITH, CH
    KALUNIAN, K
    LIANG, M
    MADDISON, P
    NIVED, O
    RICHTER, M
    SNAITH, M
    SYMMONS, D
    UROWITZ, M
    ZOMA, A
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (10) : 1395 - 1396
  • [7] PROLACTIN - A STIMULATOR OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    WALKER, SE
    ALLEN, SH
    HOFFMAN, RW
    MCMURRAY, RW
    LUPUS, 1995, 4 (01) : 3 - 9
  • [8] THE LUPUS BAND TEST AS A MEASURE OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    HALBERG, P
    ULLMAN, S
    JORGENSEN, F
    ARCHIVES OF DERMATOLOGY, 1982, 118 (08) : 572 - 576
  • [9] SYSTEMIC LUPUS-ERYTHEMATOSUS ACTIVITY AND IGE
    REBHUN, J
    QUISMORIO, F
    DUBOIS, E
    HEINER, DC
    ANNALS OF ALLERGY, 1983, 50 (01): : 34 - 36
  • [10] VALIDITY OF RETROSPECTIVE DISEASE-ACTIVITY ASSESSMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ARCESALINAS, A
    CARDIEL, MH
    GUZMAN, J
    ALCOCERVARELA, J
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 417 - 417